Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, approved the addition of 1ml: 0.1 g specifications to this product and passed the consistent evaluation of generic drug quality and efficacy (“consistency evaluation”). This medicine is suitable for the prevention and treatment of vitamin Bdeficiency.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.